Literature DB >> 6103414

Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.

W D Watkins, M B Peterson, R K Crone, D C Shannon, L Levine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103414     DOI: 10.1016/s0140-6736(80)91522-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

Review 1.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

2.  The treatment of primary pulmonary hypertension.

Authors:  N G Uren; C M Oakley
Journal:  Br Heart J       Date:  1991-08

Review 3.  Two-pore potassium channels in the cardiovascular system.

Authors:  Alison Gurney; Boris Manoury
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

Review 4.  Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.

Authors:  Rubin M Tuder; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

Review 5.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 6.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

7.  Borage or primrose oil added to standardized diets are equivalent sources for gamma-linolenic acid in rats.

Authors:  D Raederstorff; U Moser
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

Review 8.  [Pulmonary hypertension. Pathophysiology and current concepts of medication therapy].

Authors:  H Wilkens
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

9.  Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery.

Authors:  J Kermode; W Butt; F Shann
Journal:  Br Heart J       Date:  1991-08

Review 10.  Recognition and management of pulmonary hypertension.

Authors:  J C Wanstall; T K Jeffery
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.